# Evkeeza

NDC: 61755-013
Generic name: evinacumab
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20210211

FDA application: BLA761181

## Active ingredients

- EVINACUMAB: 150 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-013"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-013
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73412138-6d8f-4ea6-bb72-a740190470ff